164 related articles for article (PubMed ID: 34526175)
1. Cervical lymphadenopathy following coronavirus disease 2019 vaccine: clinical characteristics and implications for head and neck cancer services.
Abou-Foul AK; Ross E; Abou-Foul M; George AP
J Laryngol Otol; 2021 Nov; 135(11):1025-1030. PubMed ID: 34526175
[TBL] [Abstract][Full Text] [Related]
2. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy.
Hagen C; Nowack M; Messerli M; Saro F; Mangold F; Bode PK
Swiss Med Wkly; 2021 Jul; 151():w20557. PubMed ID: 34286849
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.
Faermann R; Nissan N; Halshtok-Neiman O; Shalmon A; Gotlieb M; Yagil Y; Samoocha D; Friedman E; Sklair-Levy M
Acad Radiol; 2021 Sep; 28(9):1191-1197. PubMed ID: 34257025
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccine-induced lymphadenopathies: incidence, course and imaging features from an ultrasound prospective study.
Romeo V; Stanzione A; D'Auria D; Fulgione L; Giusto F; Maurea S; Brunetti A
J Ultrasound; 2022 Dec; 25(4):965-971. PubMed ID: 35507248
[TBL] [Abstract][Full Text] [Related]
5. The impact of coronavirus disease 2019 on head and neck cancer services: a UK tertiary centre study.
Taylor R; Omakobia E; Sood S; Glore RJ
J Laryngol Otol; 2020 Aug; 134(8):684-687. PubMed ID: 32758307
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature.
Lim J; Lee SA; Khil EK; Byeon SJ; Kang HJ; Choi JA
Semin Oncol; 2021; 48(4-6):283-291. PubMed ID: 34836672
[TBL] [Abstract][Full Text] [Related]
7. Massive Cervical Lymphadenopathy Post-COVID-19 Vaccination.
Ganga K; Solyar AY; Ganga R
Ear Nose Throat J; 2024 Apr; 103(4):255-257. PubMed ID: 34601889
[TBL] [Abstract][Full Text] [Related]
8. Atypical Sites of Lymphadenopathy after Anti-COVID-19 Vaccine: Ultrasound Features.
Cocco G; Delli Pizzi A; Taraschi AL; Boccatonda A; Corvino A; Ucciferri C; Falasca K; Caulo M; Vecchiet J
Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208521
[No Abstract] [Full Text] [Related]
9. COVID-19 vaccination and low cervical lymphadenopathy in the two week neck lump clinic - a follow up audit.
Mitchell OR; Couzins M; Dave R; Bekker J; Brennan PA
Br J Oral Maxillofac Surg; 2021 Jul; 59(6):720-721. PubMed ID: 33947605
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 vaccine associated axillary lymphadenopathy - A systematic review.
Co M; Wong PCP; Kwong A
Cancer Treat Res Commun; 2022; 31():100546. PubMed ID: 35334408
[TBL] [Abstract][Full Text] [Related]
11. Management of Unilateral Axillary Lymphadenopathy Detected on Breast MRI in the Era of COVID-19 Vaccination.
Edmonds CE; Zuckerman SP; Conant EF
AJR Am J Roentgenol; 2021 Oct; 217(4):831-834. PubMed ID: 33543649
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccine associated cervical lymphadenopathy: a case series.
Heaven CL; Barber L; Ahmadi O; Selvarajah K; Shetty S
ANZ J Surg; 2022 Sep; 92(9):2286-2291. PubMed ID: 35588265
[TBL] [Abstract][Full Text] [Related]
13. Analysis of clinical factors and ultrasound features associated with COVID-19 vaccine-related axillary lymphadenopathy: A large group study.
Lim J; Khil EK; Lee SA; Choi JA; Lee KY; Jo SW; Lee J
Clin Imaging; 2024 Jan; 105():110046. PubMed ID: 38039749
[TBL] [Abstract][Full Text] [Related]
14. Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients.
Özütemiz C; Krystosek LA; Church AL; Chauhan A; Ellermann JM; Domingo-Musibay E; Steinberger D
Radiology; 2021 Jul; 300(1):E296-E300. PubMed ID: 33625300
[TBL] [Abstract][Full Text] [Related]
15. Supraclavicular lymphadenopathy secondary to COVID-19 BNT162b2 vaccine.
Roca B; Rambla M; Roca MM
J Postgrad Med; 2021; 67(3):180-181. PubMed ID: 34414929
[No Abstract] [Full Text] [Related]
16. COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management.
McIntosh LJ; Bankier AA; Vijayaraghavan GR; Licho R; Rosen MP
AJR Am J Roentgenol; 2021 Oct; 217(4):975-983. PubMed ID: 33646823
[TBL] [Abstract][Full Text] [Related]
17. Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care.
Garreffa E; Hamad A; O'Sullivan CC; Hazim AZ; York J; Puri S; Turnbull A; Robertson JF; Goetz MP
Eur J Cancer; 2021 Dec; 159():38-51. PubMed ID: 34731748
[TBL] [Abstract][Full Text] [Related]
18. The lasting impact of coronavirus disease 2019 on head and neck cancer services: a UK tertiary centre study.
Taylor R; Khan A; Omakobia E; Sood S
J Laryngol Otol; 2023 May; 137(5):537-540. PubMed ID: 36789959
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination.
Robinson KA; Maimone S; Gococo-Benore DA; Li Z; Advani PP; Chumsri S
JAMA Oncol; 2021 Sep; 7(9):1395-1397. PubMed ID: 34292295
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of elective head and neck confirmed or suspected cancer surgery during the COVID-19 pandemic.
Brar S; Ofo E; Hyde N; Kim D; Odutoye T; Allin D; Rovira A
Eur Arch Otorhinolaryngol; 2021 Apr; 278(4):1277-1282. PubMed ID: 32671539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
